Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Lifecare

Less than 1K followers

LIFE

Oslo Børs

Medical Equipment & Services

Health Care

Overview
Ownership
Investor views

Lifecare is a Norwegian company operating in medical technology. The company specializes in research and development of solutions for diabetes. The microsensors are injected under the skin of the patient's wrist, and also function as a real-time update of the patient's glucose level. In addition, the technology provides an alarm sensor and access to historical data on the patient's glucose level. The company was established in 2006 and is headquartered in Bergen, Norway.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
12.11.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Press release31.08.2026 klo 11.11

DNB Carnegie Access: Lifecare ASA: Agrees to acquire manufacturing capacity in Bergen

Lifecare
Regulatory press release31.08.2026 klo 08.00

Lifecare ASA acquires 80% of Ocean TuniCell – securing established GMP manufacturing infrastructure in Bergen

Lifecare
Press release19.08.2026 klo 18.54

DNB Carnegie Access: Lifecare ASA: More durability, less visibility – Q2 review

Lifecare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release19.08.2026 klo 08.00

LIFE: Lifecare ASA Q2 2026 results

Lifecare
Regulatory press release12.08.2026 klo 08.00

Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST

Lifecare
Press release12.08.2026 klo 08.00

Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST

Lifecare
Regulatory press release02.07.2026 klo 08.00

LIFE: Update on production transfer and longevity programme

Lifecare
Press release02.07.2026 klo 08.00

LIFE: Update on production transfer and longevity programme

Lifecare
Regulatory press release26.06.2026 klo 18.30

LIFE: Operational update regarding Lifecare Germany GmbH (i.L)

Lifecare
Regulatory press release22.06.2026 klo 14.05

Lifecare ASA: Share capital increase registered

Lifecare
Regulatory press release22.06.2026 klo 08.00

LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation

Lifecare
Press release22.06.2026 klo 08.00

LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation

Lifecare
Regulatory press release12.06.2026 klo 18.30

Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue

Lifecare
Regulatory press release12.06.2026 klo 08.00

Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Regulatory press release11.06.2026 klo 09.10

Lifecare ASA: Mandatory notification of trade

Lifecare
Regulatory press release10.06.2026 klo 17.11

Lifecare ASA: Mandatory notification of trade

Lifecare
Regulatory press release10.06.2026 klo 08.00

LIFE: Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response

Lifecare
Press release10.06.2026 klo 08.00

Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response

Lifecare
Regulatory press release05.06.2026 klo 08.00

Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Regulatory press release03.06.2026 klo 14.15

Lifecare ASA: Mandatory notification of trade

Lifecare